Global High Affinity Nerve Growth Factor Receptor Market Research Report 2022

Published: July 2022

No. of Pages: 101

Price:

Single User License: US $ 2900

Corporate User License: US $ 5800

Report Description
Table of Contents

High Affinity Nerve Growth Factor Receptor market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global High Affinity Nerve Growth Factor Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
- ASP-7962
- AZD-7451
- BNN-27
- Cenegermin
- CRB-0089
- Others

Segment by Application
- Bile Duct Cancer
- Papillary Thyroid Cancer
- Low Back Pain
- Lung Cancer
- Others

By Region
- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- - Nordic Countries
- - Rest of Europe
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Australia
- - Rest of Asia
- Latin America
- - Mexico
- - Brazil
- - Rest of Latin America
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - UAE
- - Rest of MEA

By Company
- Array BioPharma Inc
- Astellas Pharma Inc
- AstraZeneca Plc
- Daiichi Sankyo Co Ltd
- Dompe Farmaceutici SpA
- Genzyme Corp
- Handok Inc
- Ignyta Inc
- Loxo Oncology Inc
- Merck & Co Inc
- Nerviano Medical Sciences Srl
- Plexxikon Inc
- Proximagen Ltd
- Rottapharm Biotech Srl
- Sienna Biopharmaceuticals Inc
- Tiziana Life Sciences Plc

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 ASP-7962
1.2.3 AZD-7451
1.2.4 BNN-27
1.2.5 Cenegermin
1.2.6 CRB-0089
1.2.7 Others
1.3 Market by Application
1.3.1 Global High Affinity Nerve Growth Factor Receptor Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Bile Duct Cancer
1.3.3 Papillary Thyroid Cancer
1.3.4 Low Back Pain
1.3.5 Lung Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global High Affinity Nerve Growth Factor Receptor Market Perspective (2017-2028)
2.2 High Affinity Nerve Growth Factor Receptor Growth Trends by Region
2.2.1 High Affinity Nerve Growth Factor Receptor Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 High Affinity Nerve Growth Factor Receptor Historic Market Size by Region (2017-2022)
2.2.3 High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Region (2023-2028)
2.3 High Affinity Nerve Growth Factor Receptor Market Dynamics
2.3.1 High Affinity Nerve Growth Factor Receptor Industry Trends
2.3.2 High Affinity Nerve Growth Factor Receptor Market Drivers
2.3.3 High Affinity Nerve Growth Factor Receptor Market Challenges
2.3.4 High Affinity Nerve Growth Factor Receptor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top High Affinity Nerve Growth Factor Receptor Players by Revenue
3.1.1 Global Top High Affinity Nerve Growth Factor Receptor Players by Revenue (2017-2022)
3.1.2 Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Players (2017-2022)
3.2 Global High Affinity Nerve Growth Factor Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by High Affinity Nerve Growth Factor Receptor Revenue
3.4 Global High Affinity Nerve Growth Factor Receptor Market Concentration Ratio
3.4.1 Global High Affinity Nerve Growth Factor Receptor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High Affinity Nerve Growth Factor Receptor Revenue in 2021
3.5 High Affinity Nerve Growth Factor Receptor Key Players Head office and Area Served
3.6 Key Players High Affinity Nerve Growth Factor Receptor Product Solution and Service
3.7 Date of Enter into High Affinity Nerve Growth Factor Receptor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 High Affinity Nerve Growth Factor Receptor Breakdown Data by Type
4.1 Global High Affinity Nerve Growth Factor Receptor Historic Market Size by Type (2017-2022)
4.2 Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Type (2023-2028)
5 High Affinity Nerve Growth Factor Receptor Breakdown Data by Application
5.1 Global High Affinity Nerve Growth Factor Receptor Historic Market Size by Application (2017-2022)
5.2 Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America High Affinity Nerve Growth Factor Receptor Market Size (2017-2028)
6.2 North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022)
6.3 North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe High Affinity Nerve Growth Factor Receptor Market Size (2017-2028)
7.2 Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022)
7.3 Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size (2017-2028)
8.2 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022)
8.3 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America High Affinity Nerve Growth Factor Receptor Market Size (2017-2028)
9.2 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022)
9.3 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size (2017-2028)
10.2 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022)
10.3 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Array BioPharma Inc
11.1.1 Array BioPharma Inc Company Detail
11.1.2 Array BioPharma Inc Business Overview
11.1.3 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Introduction
11.1.4 Array BioPharma Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.1.5 Array BioPharma Inc Recent Development
11.2 Astellas Pharma Inc
11.2.1 Astellas Pharma Inc Company Detail
11.2.2 Astellas Pharma Inc Business Overview
11.2.3 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Introduction
11.2.4 Astellas Pharma Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.2.5 Astellas Pharma Inc Recent Development
11.3 AstraZeneca Plc
11.3.1 AstraZeneca Plc Company Detail
11.3.2 AstraZeneca Plc Business Overview
11.3.3 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Introduction
11.3.4 AstraZeneca Plc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.3.5 AstraZeneca Plc Recent Development
11.4 Daiichi Sankyo Co Ltd
11.4.1 Daiichi Sankyo Co Ltd Company Detail
11.4.2 Daiichi Sankyo Co Ltd Business Overview
11.4.3 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Introduction
11.4.4 Daiichi Sankyo Co Ltd Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.4.5 Daiichi Sankyo Co Ltd Recent Development
11.5 Dompe Farmaceutici SpA
11.5.1 Dompe Farmaceutici SpA Company Detail
11.5.2 Dompe Farmaceutici SpA Business Overview
11.5.3 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Introduction
11.5.4 Dompe Farmaceutici SpA Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.5.5 Dompe Farmaceutici SpA Recent Development
11.6 Genzyme Corp
11.6.1 Genzyme Corp Company Detail
11.6.2 Genzyme Corp Business Overview
11.6.3 Genzyme Corp High Affinity Nerve Growth Factor Receptor Introduction
11.6.4 Genzyme Corp Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.6.5 Genzyme Corp Recent Development
11.7 Handok Inc
11.7.1 Handok Inc Company Detail
11.7.2 Handok Inc Business Overview
11.7.3 Handok Inc High Affinity Nerve Growth Factor Receptor Introduction
11.7.4 Handok Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.7.5 Handok Inc Recent Development
11.8 Ignyta Inc
11.8.1 Ignyta Inc Company Detail
11.8.2 Ignyta Inc Business Overview
11.8.3 Ignyta Inc High Affinity Nerve Growth Factor Receptor Introduction
11.8.4 Ignyta Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.8.5 Ignyta Inc Recent Development
11.9 Loxo Oncology Inc
11.9.1 Loxo Oncology Inc Company Detail
11.9.2 Loxo Oncology Inc Business Overview
11.9.3 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Introduction
11.9.4 Loxo Oncology Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.9.5 Loxo Oncology Inc Recent Development
11.10 Merck & Co Inc
11.10.1 Merck & Co Inc Company Detail
11.10.2 Merck & Co Inc Business Overview
11.10.3 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Introduction
11.10.4 Merck & Co Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.10.5 Merck & Co Inc Recent Development
11.11 Nerviano Medical Sciences Srl
11.11.1 Nerviano Medical Sciences Srl Company Detail
11.11.2 Nerviano Medical Sciences Srl Business Overview
11.11.3 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Introduction
11.11.4 Nerviano Medical Sciences Srl Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.11.5 Nerviano Medical Sciences Srl Recent Development
11.12 Plexxikon Inc
11.12.1 Plexxikon Inc Company Detail
11.12.2 Plexxikon Inc Business Overview
11.12.3 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Introduction
11.12.4 Plexxikon Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.12.5 Plexxikon Inc Recent Development
11.13 Proximagen Ltd
11.13.1 Proximagen Ltd Company Detail
11.13.2 Proximagen Ltd Business Overview
11.13.3 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Introduction
11.13.4 Proximagen Ltd Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.13.5 Proximagen Ltd Recent Development
11.14 Rottapharm Biotech Srl
11.14.1 Rottapharm Biotech Srl Company Detail
11.14.2 Rottapharm Biotech Srl Business Overview
11.14.3 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Introduction
11.14.4 Rottapharm Biotech Srl Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.14.5 Rottapharm Biotech Srl Recent Development
11.15 Sienna Biopharmaceuticals Inc
11.15.1 Sienna Biopharmaceuticals Inc Company Detail
11.15.2 Sienna Biopharmaceuticals Inc Business Overview
11.15.3 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Introduction
11.15.4 Sienna Biopharmaceuticals Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.15.5 Sienna Biopharmaceuticals Inc Recent Development
11.16 Tiziana Life Sciences Plc
11.16.1 Tiziana Life Sciences Plc Company Detail
11.16.2 Tiziana Life Sciences Plc Business Overview
11.16.3 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Introduction
11.16.4 Tiziana Life Sciences Plc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
11.16.5 Tiziana Life Sciences Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of ASP-7962
Table 3. Key Players of AZD-7451
Table 4. Key Players of BNN-27
Table 5. Key Players of Cenegermin
Table 6. Key Players of CRB-0089
Table 7. Key Players of Others
Table 8. Global High Affinity Nerve Growth Factor Receptor Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global High Affinity Nerve Growth Factor Receptor Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global High Affinity Nerve Growth Factor Receptor Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global High Affinity Nerve Growth Factor Receptor Market Share by Region (2017-2022)
Table 12. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global High Affinity Nerve Growth Factor Receptor Market Share by Region (2023-2028)
Table 14. High Affinity Nerve Growth Factor Receptor Market Trends
Table 15. High Affinity Nerve Growth Factor Receptor Market Drivers
Table 16. High Affinity Nerve Growth Factor Receptor Market Challenges
Table 17. High Affinity Nerve Growth Factor Receptor Market Restraints
Table 18. Global High Affinity Nerve Growth Factor Receptor Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global High Affinity Nerve Growth Factor Receptor Market Share by Players (2017-2022)
Table 20. Global Top High Affinity Nerve Growth Factor Receptor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High Affinity Nerve Growth Factor Receptor as of 2021)
Table 21. Ranking of Global Top High Affinity Nerve Growth Factor Receptor Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by High Affinity Nerve Growth Factor Receptor Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players High Affinity Nerve Growth Factor Receptor Product Solution and Service
Table 25. Date of Enter into High Affinity Nerve Growth Factor Receptor Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global High Affinity Nerve Growth Factor Receptor Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2017-2022)
Table 29. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2023-2028)
Table 31. Global High Affinity Nerve Growth Factor Receptor Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2017-2022)
Table 33. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2023-2028)
Table 35. North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022) & (US$ Million)
Table 38. Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028) & (US$ Million)
Table 39. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Region (2017-2022) & (US$ Million)
Table 40. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Region (2023-2028) & (US$ Million)
Table 41. Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022) & (US$ Million)
Table 42. Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028) & (US$ Million)
Table 43. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022) & (US$ Million)
Table 44. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2023-2028) & (US$ Million)
Table 45. Array BioPharma Inc Company Detail
Table 46. Array BioPharma Inc Business Overview
Table 47. Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Product
Table 48. Array BioPharma Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 49. Array BioPharma Inc Recent Development
Table 50. Astellas Pharma Inc Company Detail
Table 51. Astellas Pharma Inc Business Overview
Table 52. Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Product
Table 53. Astellas Pharma Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 54. Astellas Pharma Inc Recent Development
Table 55. AstraZeneca Plc Company Detail
Table 56. AstraZeneca Plc Business Overview
Table 57. AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Product
Table 58. AstraZeneca Plc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 59. AstraZeneca Plc Recent Development
Table 60. Daiichi Sankyo Co Ltd Company Detail
Table 61. Daiichi Sankyo Co Ltd Business Overview
Table 62. Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Product
Table 63. Daiichi Sankyo Co Ltd Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 64. Daiichi Sankyo Co Ltd Recent Development
Table 65. Dompe Farmaceutici SpA Company Detail
Table 66. Dompe Farmaceutici SpA Business Overview
Table 67. Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Product
Table 68. Dompe Farmaceutici SpA Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 69. Dompe Farmaceutici SpA Recent Development
Table 70. Genzyme Corp Company Detail
Table 71. Genzyme Corp Business Overview
Table 72. Genzyme Corp High Affinity Nerve Growth Factor Receptor Product
Table 73. Genzyme Corp Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 74. Genzyme Corp Recent Development
Table 75. Handok Inc Company Detail
Table 76. Handok Inc Business Overview
Table 77. Handok Inc High Affinity Nerve Growth Factor Receptor Product
Table 78. Handok Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 79. Handok Inc Recent Development
Table 80. Ignyta Inc Company Detail
Table 81. Ignyta Inc Business Overview
Table 82. Ignyta Inc High Affinity Nerve Growth Factor Receptor Product
Table 83. Ignyta Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 84. Ignyta Inc Recent Development
Table 85. Loxo Oncology Inc Company Detail
Table 86. Loxo Oncology Inc Business Overview
Table 87. Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Product
Table 88. Loxo Oncology Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 89. Loxo Oncology Inc Recent Development
Table 90. Merck & Co Inc Company Detail
Table 91. Merck & Co Inc Business Overview
Table 92. Merck & Co Inc High Affinity Nerve Growth Factor Receptor Product
Table 93. Merck & Co Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 94. Merck & Co Inc Recent Development
Table 95. Nerviano Medical Sciences Srl Company Detail
Table 96. Nerviano Medical Sciences Srl Business Overview
Table 97. Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor ReceptorProduct
Table 98. Nerviano Medical Sciences Srl Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 99. Nerviano Medical Sciences Srl Recent Development
Table 100. Plexxikon Inc Company Detail
Table 101. Plexxikon Inc Business Overview
Table 102. Plexxikon Inc High Affinity Nerve Growth Factor ReceptorProduct
Table 103. Plexxikon Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 104. Plexxikon Inc Recent Development
Table 105. Proximagen Ltd Company Detail
Table 106. Proximagen Ltd Business Overview
Table 107. Proximagen Ltd High Affinity Nerve Growth Factor ReceptorProduct
Table 108. Proximagen Ltd Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 109. Proximagen Ltd Recent Development
Table 110. Rottapharm Biotech Srl Company Detail
Table 111. Rottapharm Biotech Srl Business Overview
Table 112. Rottapharm Biotech Srl High Affinity Nerve Growth Factor ReceptorProduct
Table 113. Rottapharm Biotech Srl Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 114. Rottapharm Biotech Srl Recent Development
Table 115. Sienna Biopharmaceuticals Inc Company Detail
Table 116. Sienna Biopharmaceuticals Inc Business Overview
Table 117. Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor ReceptorProduct
Table 118. Sienna Biopharmaceuticals Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 119. Sienna Biopharmaceuticals Inc Recent Development
Table 120. Tiziana Life Sciences Plc Company Detail
Table 121. Tiziana Life Sciences Plc Business Overview
Table 122. Tiziana Life Sciences Plc High Affinity Nerve Growth Factor ReceptorProduct
Table 123. Tiziana Life Sciences Plc Revenue in High Affinity Nerve Growth Factor Receptor Business (2017-2022) & (US$ Million)
Table 124. Tiziana Life Sciences Plc Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global High Affinity Nerve Growth Factor Receptor Market Share by Type: 2021 VS 2028
Figure 2. ASP-7962 Features
Figure 3. AZD-7451 Features
Figure 4. BNN-27 Features
Figure 5. Cenegermin Features
Figure 6. CRB-0089 Features
Figure 7. Others Features
Figure 8. Global High Affinity Nerve Growth Factor Receptor Market Share by Application in 2021 & 2028
Figure 9. Bile Duct Cancer Case Studies
Figure 10. Papillary Thyroid Cancer Case Studies
Figure 11. Low Back Pain Case Studies
Figure 12. Lung Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. High Affinity Nerve Growth Factor Receptor Report Years Considered
Figure 15. Global High Affinity Nerve Growth Factor Receptor Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global High Affinity Nerve Growth Factor Receptor Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global High Affinity Nerve Growth Factor Receptor Market Share by Region: 2021 VS 2028
Figure 18. Global High Affinity Nerve Growth Factor Receptor Market Share by Players in 2021
Figure 19. Global Top High Affinity Nerve Growth Factor Receptor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High Affinity Nerve Growth Factor Receptor as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by High Affinity Nerve Growth Factor Receptor Revenue in 2021
Figure 21. North America High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. North America High Affinity Nerve Growth Factor Receptor Market Share by Country (2017-2028)
Figure 23. United States High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe High Affinity Nerve Growth Factor Receptor Market Share by Country (2017-2028)
Figure 27. Germany High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Share by Region (2017-2028)
Figure 35. China High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America High Affinity Nerve Growth Factor Receptor Market Share by Country (2017-2028)
Figure 43. Mexico High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Brazil High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Share by Country (2017-2028)
Figure 47. Turkey High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Saudi Arabia High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Array BioPharma Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 50. Astellas Pharma Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 51. AstraZeneca Plc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 52. Daiichi Sankyo Co Ltd Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 53. Dompe Farmaceutici SpA Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 54. Genzyme Corp Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 55. Handok Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 56. Ignyta Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 57. Loxo Oncology Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 58. Merck & Co Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 59. Nerviano Medical Sciences Srl Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 60. Plexxikon Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 61. Proximagen Ltd Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 62. Rottapharm Biotech Srl Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 63. Sienna Biopharmaceuticals Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 64. Tiziana Life Sciences Plc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group1840204

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Global High Affinity Nerve Growth Factor Receptor Market Insights, Forecast to 2028 High Affinity Nerve Growth Factor Receptor market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global High Affinity Nerve Growth Factor Receptor market will be able to gai...
Global High Affinity Nerve Growth Factor Receptor Market Research Report 2021 The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...
Global High Affinity Nerve Growth Factor Receptor Market Size, Status and Forecast 2021-2027 Market Analysis and Insights: Global High Affinity Nerve Growth Factor Receptor Market The global High Affinity Nerve Growth Factor Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX...
Global and United States High Affinity Nerve Growth Factor Receptor Market Size, Status and Forecast 2021-2027 Global High Affinity Nerve Growth Factor Receptor Scope and Market Size High Affinity Nerve Growth Factor Receptor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in ...
High Affinity Nerve Growth Factor Receptor Market - Global Outlook and Forecast 2021-2027 This report contains market size and forecasts of High Affinity Nerve Growth Factor Receptor in Global, including the following market information: Global High Affinity Nerve Growth Factor Receptor Market Revenue, 2016-2021, 2022-2027, ($ mill...
High Affinity Nerve Growth Factor Receptor Market Insights 2019, Global and Chinese Analysis and Forecast to 2024 High Affinity Nerve Growth Factor Receptor Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global High Affinity Nerve Growth Factor Receptor industry with a focus on the Chinese marke...
High Affinity Nerve Growth Factor Receptor - Pipeline Review, H1 2020 High Affinity Nerve Growth Factor Receptor - Pipeline Review, H1 2020 Summary High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyos...
2020-2025 Global and Regional High Affinity Nerve Growth Factor Receptor Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report HNY Research projects that the High Affinity Nerve Growth Factor Receptor market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to...
TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonist - Pipeline Insight, 2020 Overview "TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonist - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects acros...
Global High Affinity Nerve Growth Factor Receptor Market Insights and Forecast to 2026 High Affinity Nerve Growth Factor Receptor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global High Affinity Nerve Growth Factor Receptor market will be able to gain the upper hand as they use ...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *